Cyclosporine Inhibits the Development of Green Fluorescent Protein (GFP)-Specific Immune Responses After Transplantation of GFP-Expressing Hematopoietic Repopulating Cells in Dogs-Reference-Cited by-同舟云学术

Cyclosporine Inhibits the Development of Green Fluorescent Protein (GFP)-Specific Immune Responses After Transplantation of GFP-Expressing Hematopoietic Repopulating Cells in Dogs

Published:2005-06 Issue:6 Volume:16 Page:725-733
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Beagles K.E.¹,Peterson L.¹,Zhang X.¹,Morris J.¹,Kiem H.-P.¹²

Affiliation:

1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.

2. Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2005.16.725

Reference25 articles.

1. Marking and Gene Expression by a Lentivirus Vector in Transplanted Human and Nonhuman Primate CD34 + Cells

2. Lentivirus Vector-Mediated Hematopoietic Stem Cell Gene Transfer of Common Gamma-Chain Cytokine Receptor in Rhesus Macaques

3. Functions of NF-κB1 and NF-κB2 in immune cell biology

4. Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir

5. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4;Blood Advances;2022-07-29

2. Immunological barriers to haematopoietic stem cell gene therapy;Nature Reviews Immunology;2022-03-17

3. Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines;Acta Biomaterialia;2021-08

4. Genetic Modification of Mesenchymal Stem Cells for Neurological Disease Therapy: What Effects Does it Have on Phenotype/Cell Behavior, Determining Their Effectiveness?;Molecular Diagnosis & Therapy;2020-09-14

5. mRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification;Scientific Reports;2020-03-06